The clinical knowledge archive
Technical guides behind the Payarmin label
Eight monographs that answer the questions a 22-ingredient blood-sugar dropper raises: how it is absorbed, what a proprietary blend hides, which biomarkers to track, and which interactions to check. Each cites primary sources.
Cellular Absorption Pathways: What a Liquid Dropper Changes, and What It Doesn't
Liquid supplements are often sold as faster or better absorbed. For a product you swallow, the gut does the absorbing either way.
Technical dossier · 3 minWhy Standardized Botanical Extracts Outperform Plain Plant Names
Two bottles can both say 'gymnema leaf extract' and contain very different amounts of the compounds that matter.
Investigation · 3 minCounterfeit and Grey-Market Supplements: An Investigation for Buyers
Not every marketplace bottle is fake. But every marketplace bottle sits outside the maker's paper trail and refund.
Clinical primer · 3 minTimeline Expectations: The Biomarkers That Matter in the First 90 Days
Supplements are judged by feelings far too often. Blood sugar is one of the few areas where you can measure.
Technical dossier · 3 minMicronutrient Synergy Index: Chromium, Cofactors and the Dose Question
Chromium is in almost every blood-sugar formula. The amount is what separates a meaningful dose from a label decoration.
Regulatory dossier · 3 minClean Manufacturing: What cGMP Audits and USP 2232 Testing Really Mean
'Made in a cGMP facility' is the legal minimum. Here is what sits behind it, and what does not.
Label literacy · 3 minProprietary Blends Explained: How to Read a 200 mg Blend of 22
A proprietary blend tells you the total and the order. With arithmetic, that is more than it first seems.
Safety dossier · 3 minSupplement and Drug Interactions in a Blood-Sugar Formula
Payarmin's amounts are small, but four of its ingredients belong on any interaction checklist.